Raymond James Financial Services Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,497
| Closed | -$226K | – | 3383 |
|
|
2022
Q3 | $226K | Sell |
1,497
-159
| -10% | -$24K | ﹤0.01% | 2764 |
|
|
2022
Q2 | $241K | Sell |
1,656
-600
| -27% | -$87.3K | ﹤0.01% | 2747 |
|
|
2022
Q1 | $267K | Sell |
2,256
-15
| -0.7% | -$1.78K | ﹤0.01% | 2798 |
|
|
2021
Q4 | $313K | Buy |
2,271
+188
| +9% | +$25.9K | ﹤0.01% | 2677 |
|
|
2021
Q3 | $289K | Sell |
2,083
-97
| -4% | -$13.5K | ﹤0.01% | 2710 |
|
|
2021
Q2 | $212K | Buy |
+2,180
| New | +$212K | ﹤0.01% | 2974 |
|
|
2020
Q1 | – | Sell |
-6,979
| Closed | -$380K | – | 2938 |
|
|
2019
Q4 | $380K | Buy |
6,979
+84
| +1% | +$4.57K | ﹤0.01% | 2161 |
|
|
2019
Q3 | $288K | Sell |
6,895
-100
| -1% | -$4.18K | ﹤0.01% | 2272 |
|
|
2019
Q2 | $306K | Sell |
6,995
-704
| -9% | -$30.8K | ﹤0.01% | 2260 |
|
|
2019
Q1 | $396K | Buy |
7,699
+75
| +1% | +$3.86K | ﹤0.01% | 2038 |
|
|
2018
Q4 | $282K | Hold |
7,624
| – | – | ﹤0.01% | 2038 |
|
|
2018
Q3 | $286K | Buy |
7,624
+250
| +3% | +$9.38K | ﹤0.01% | 2310 |
|
|
2018
Q2 | $291K | Buy |
+7,374
| New | +$291K | ﹤0.01% | 2253 |
|